Codex Capital, L.L.C. Regeneron Pharmaceuticals, Inc. Transaction History
Codex Capital, L.L.C.
- $205 Billion
- Q1 2024
A detailed history of Codex Capital, L.L.C. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Codex Capital, L.L.C. holds 5,750 shares of REGN stock, worth $4.35 Million. This represents 2.7% of its overall portfolio holdings.
Number of Shares
5,750
Previous 5,750
-0.0%
Holding current value
$4.35 Million
Previous $5.05 Billion
9.59%
% of portfolio
2.7%
Previous 2.95%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,529Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.05 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.39 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.67 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.71 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.25 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $81.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...